FDA Drug Approval, A072079, DIAZEPAM
FDA Drug Approval, A072079, DIAZEPAM
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
Contents: Summary Basis of Approval
ANDA: 072079
Company: HOSPIRA
Drug Name: DIAZEPAM
Active Ingredients: DIAZEPAM
Strength: 10MG/2ML (5MG/ML)
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 12/20/1988
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AP
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details